Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
2014 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Is inappropriate medication use a major cause of adverse drug reactions in the elderly?
2006
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
2009
Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
1993 Standout
What is polypharmacy? A systematic review of definitions
2017 Standout
Parenteral Anticoagulants
2012 Standout
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
2021
Advances in the Management of Digoxin Toxicity in the Older Patient
1997
Testing for zopiclone in hair application to drug-facilitated crimes
2004
Consensus meetings on: Causality assessment of drug-induced liver injury
1988
Utilisation and Safety of Low Molecular Weight Heparins
2003
Perifollicular Xanthomatosis as the Hallmark of Axillary Fox-Fordyce Disease
2008 Standout
Testing for the Undetectable in Drug-Facilitated Sexual Assault Using Hair Analyzed by Tandem Mass Spectrometry as Evidence
2004
Frailty Consensus: A Call to Action
2013 Standout
Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge
1993
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2015
Burden of liver diseases in the world
2018 Standout
Adverse drug reactions: definitions, diagnosis, and management
2000 Standout
Management of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome): An Update
2003
Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey
2015
Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation
2017
Assessing methods for causality assessment of suspected adverse drug reactions
1989
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Perhexiline
2007
Drug-Induced Hepatotoxicity
2003 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES)
2007
From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak
2011
Psoriasis
2021 Standout
Paracetamol, alcohol and the liver
2000
Designing Predictive Models for Beta-Lactam Allergy Using the Drug Allergy and Hypersensitivity Database
2017
Emergency Department Visits Caused by Adverse Drug Events
2007
State of the art in hair analysis for detection of drug and alcohol abuse
2006 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Drug-Induced Hypersensitivity Syndrome
2009
A Controlled Trial of Bismuth Subsalicylate in Infants with Acute Watery Diarrheal Disease
1993
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2017
Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
1989
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
1991
Characteristics of Medication Errors in Pediatrics
1991
Hair analysis by liquid chromatography–tandem mass spectrometry in toxicological investigation of drug-facilitated crimes: Report of 128 cases over the period June 2003–May 2004 in metropolitan Paris
2005
American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006
2007
Myocarditis
2011 Standout
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
2022
Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
1989
Prevention of Venous Thromboembolism
2004 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Acetaminophen‐induced acute liver failure
2005 Standout
Incidence of drug-induced hepatic injuries: A French population-based study
2002
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Quantitative signal detection using spontaneous ADR reporting
2009
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
2023 Standout
Prevention of Venous Thromboembolism
2008 Standout
The ChEMBL database in 2017
2016 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
Predicting and Preventing Adverse Drug Reactions in the Very Old
2005
Down syndrome
2020 Standout
Management of Crohn's Disease in Adults
2009 Standout
Buprenorphine in Drug-Facilitated Sexual Abuse: A Fatal Case Involving a 14-Year-Old Boy
2003
Trastuzumab-Induced Hepatotoxicity: A Case Report
2013 Standout
The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients
2003
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Adverse Effects of Voriconazole: Analysis of the French Pharmacovigilance Database
2007
Causality classification at pharmacovigilance centres in the european community
1992
Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure
1995
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Toxic effects of metals
1991 Standout
Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999
2001
Criteria of drug-induced liver disorders
1990 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
ADVERSE DRUG REACTION MONITORING: DOING IT THE FRENCH WAY
1985
2013
Pharmacokinetics and Toxicity of Bismuth Compounds
1989
Drug-related microscopic colitis: A case induced by Fluindione
2011
Costs and Benefits of Health Information Technology
2006 Standout
The Diagnosis of Adverse Medical Events Associated with Drug Treatment
1988
Works of G Lagier being referenced
[Hypoglycemia in 2 patients treated with perhexiline maleate].
1977
Appraisal of the MedDRA Conceptual Structure for Describing and Grouping Adverse Drug Reactions
2005
[Does hepatitis due to subacute paracetamol toxicity exist? Apropos of 3 possible cases].
1988
[A minor case of ergotism appearing to be connected with a potentialisation of ergotamine tartrate by erythromycine ethyl-succinate (author's transl)].
1980
[Drug-induced cutaneous photosensitivity. Results of a consensus meeting].
1989
[Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France].
1985
[Prognostic factors in acute digitalis poisoning (author's transl)].
1981
[Differential diagnosis of drug induced leucopenias (Weighted Assessment Method [W.A.M.] )].
1982
[Presentation of data in drug surveillance and bases for a decision].
1986
[Drug-induced hemolytic anemia. Results of consensus conferences].
1988
Quantitative modifications of major histocompatibility complex (MHC) antigens induced by recombinant gamma interferon in two human breast cancer lines
1987
[Accidental misuse of drugs (author's transl)].
1980
[Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid].
1983
[Bismuth encephalopathies outside France (author's transl)].
1980
[Drug-induced renal insufficiency. Results of consensus meetings].
1989
A Drug Information-ADR Collection Network: The French System
1986
[Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
1987
[Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings].
1987
[Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].
1983
Usage criminel de produits psychoactifs : analyse d'une série parisienne
2002
[Guide for the imputability of drug-induced hepatitis].
1985
[Interstitial pneumopathies: criteria of drug side-effects. Results of consensus meetings].
1989